Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.5M Sell
97,200
-23,300
-19% -$7.39M ﹤0.01% 2183
2026
Q1
$30.2M Sell
120,500
-171,300
-59% -$38M ﹤0.01% 2164
2025
Q4
$47.3M Sell
291,800
-160,500
-35% -$27.9M 0.01% 1682
2025
Q3
$68.2M Sell
452,300
-191,800
-30% -$25.6M 0.01% 1339
2025
Q2
$82.7M Buy
644,100
+127,700
+25% +$12.4M 0.01% 1111
2025
Q1
$37.3M Buy
516,400
+514,300
+24,490% +$54.7M 0.01% 1742
2024
Q4
$239K Sell
2,100
-77,000
-97% -$9.14M ﹤0.01% 6345
2024
Q3
$7.87M Buy
79,100
+69,100
+691% +$5.73M ﹤0.01% 2606
2024
Q2
$866K Sell
10,000
-1,097,800
-99% -$99.9M ﹤0.01% 4541
2024
Q1
$90.5M Buy
+1,107,800
New +$69.6M 0.02% 698
2023
Q3
Sell
-100,000
Closed -$2.48M 10003
2023
Q2
$2.48M Buy
+100,000
New +$1.72M ﹤0.01% 3326

Other funds holding VRT

UBS Group's VRT Position: Q2 2026 in Review

UBS Group reduced its Vertiv (VRT) stake by 34% in Q2 2026, selling an estimated $579M and leaving 3,622,661 shares worth $1.21B. The position accounts for 0.15% of the portfolio, ranked #121.

UBS Group first reported a position in VRT in Q2 2019 and has held it in 29 quarters since. The position peaked at $1.37B in Q1 2026. 2,057 funds tracked by Wall St. Rank hold VRT as of Q2 2026.

  • UBS Group held 3,622,661 shares of Vertiv worth $1.21B as of Q2 2026.
  • UBS Group sold 1,825,912 Vertiv shares in Q2 2026, an estimated $579M.
  • Vertiv made up 0.15% of UBS Group's portfolio in Q2 2026, its #121 holding.
  • UBS Group first reported a position in Vertiv in Q2 2019 and has held it in 29 quarters since.
  • UBS Group's Vertiv position peaked at $1.37B in Q1 2026.
  • 2,057 funds tracked by Wall St. Rank held Vertiv as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.